Skip to content
10-Q

Quarterly Report

LogicBio Therapeutics, Inc.

0001564590-22-029395

← back to feed
Filed
Aug 15, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2022 · Aug 9, 2022 32.96M sh
Shares Diluted Q2 2022 · Jun 30, 2022 32.96M sh
Shares Diluted Q2 2022 · Jun 30, 2022 32.96M sh
Shares Diluted Q2 2022 · Jun 30, 2021 32.16M sh
Shares Diluted Q2 2022 · Jun 30, 2021 32.05M sh
Capex Q2 2022 · Jun 30, 2022 $47K
Capex Q2 2022 · Jun 30, 2021 $352K
Operating Cash Flow Q2 2022 · Jun 30, 2022 −$12.92M
Operating Cash Flow Q2 2022 · Jun 30, 2021 −$3.53M
Long Term Debt Q2 2022 · Jun 30, 2022 $3.42M
Long Term Debt Q2 2022 · Dec 31, 2021 $5.01M
Short Term Debt Q2 2022 · Jun 30, 2022 $3.3M
Short Term Debt Q2 2022 · Dec 31, 2021 $3.3M
Cash And Equivalents Q2 2022 · Jun 30, 2022 $38.85M
Cash And Equivalents Q2 2022 · Dec 31, 2021 $53.48M
Cash And Equivalents Q2 2022 · Jun 30, 2021 $68.11M
Stockholders Equity Q2 2022 · Jun 30, 2022 $20.72M
Stockholders Equity Q2 2022 · Dec 31, 2021 $30.73M
Current Liabilities Q2 2022 · Jun 30, 2022 $18.09M
Current Liabilities Q2 2022 · Dec 31, 2021 $19.58M
Total Liabilities Q2 2022 · Jun 30, 2022 $26.3M
Total Liabilities Q2 2022 · Dec 31, 2021 $32.04M
Current Assets Q2 2022 · Jun 30, 2022 $40.79M
Current Assets Q2 2022 · Dec 31, 2021 $55.67M
Total Assets Q2 2022 · Jun 30, 2022 $47.02M
Total Assets Q2 2022 · Dec 31, 2021 $62.77M
Eps Diluted Q2 2022 · Jun 30, 2022 −$0.15
Eps Diluted Q2 2022 · Jun 30, 2022 −$0.36
Eps Diluted Q2 2022 · Jun 30, 2021 −$0.33
Eps Diluted Q2 2022 · Jun 30, 2021 −$0.65
Eps Basic Q2 2022 · Jun 30, 2022 −$0.15
Eps Basic Q2 2022 · Jun 30, 2022 −$0.36
Eps Basic Q2 2022 · Jun 30, 2021 −$0.33
Eps Basic Q2 2022 · Jun 30, 2021 −$0.65
Sga Expense Q2 2022 · Jun 30, 2022 $3.26M
Sga Expense Q2 2022 · Jun 30, 2022 $6.88M
Sga Expense Q2 2022 · Jun 30, 2021 $3.77M
Sga Expense Q2 2022 · Jun 30, 2021 $7.82M
Rd Expense Q2 2022 · Jun 30, 2022 $4.83M
Rd Expense Q2 2022 · Jun 30, 2022 $10.47M
Rd Expense Q2 2022 · Jun 30, 2021 $7.26M
Rd Expense Q2 2022 · Jun 30, 2021 $13.68M
Net Income Q2 2022 · Jun 30, 2022 −$5.04M
Net Income Q2 2022 · Jun 30, 2022 −$11.71M
Net Income Q2 2022 · Mar 31, 2022 −$6.66M
Net Income Q2 2022 · Jun 30, 2021 −$10.5M
Net Income Q2 2022 · Jun 30, 2021 −$20.78M
Net Income Q2 2022 · Mar 31, 2021 −$10.28M
Operating Income Q2 2022 · Jun 30, 2022 −$4.89M
Operating Income Q2 2022 · Jun 30, 2022 −$11.34M
Operating Income Q2 2022 · Jun 30, 2021 −$10.22M
Operating Income Q2 2022 · Jun 30, 2021 −$20.24M
Revenue Q2 2022 · Jun 30, 2022 $3.2M
Revenue Q2 2022 · Jun 30, 2022 $6.02M
Revenue Q2 2022 · Jun 30, 2021 $802K
Revenue Q2 2022 · Jun 30, 2021 $1.26M